247 related articles for article (PubMed ID: 15755849)
1. 15-Deoxy-{delta}12,14-prostaglandin j2 inhibits interleukin-1{beta}-induced nuclear factor-{kappa}b in human amnion and myometrial cells: mechanisms and implications.
Lindström TM; Bennett PR
J Clin Endocrinol Metab; 2005 Jun; 90(6):3534-43. PubMed ID: 15755849
[TBL] [Abstract][Full Text] [Related]
2. Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B.
Berry EB; Keelan JA; Helliwell RJ; Gilmour RS; Mitchell MD
Mol Pharmacol; 2005 Jul; 68(1):169-78. PubMed ID: 15821150
[TBL] [Abstract][Full Text] [Related]
3. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells.
Sawano H; Haneda M; Sugimoto T; Inoki K; Koya D; Kikkawa R
Kidney Int; 2002 Jun; 61(6):1957-67. PubMed ID: 12028436
[TBL] [Abstract][Full Text] [Related]
4. The 15-deoxy-Delta12,14-prostaglandin J2 inhibits LPS-stimulated AKT and NF-kappaB activation and suppresses interleukin-6 in osteoblast-like cells MC3T3E-1.
Jung WK; Park IS; Park SJ; Yea SS; Choi YH; Oh S; Park SG; Choi IW
Life Sci; 2009 Jul; 85(1-2):46-53. PubMed ID: 19409914
[TBL] [Abstract][Full Text] [Related]
5. The cyclopentenone 15-deoxy-delta 12,14-prostaglandin J(2) delays lipopolysaccharide-induced preterm delivery and reduces mortality in the newborn mouse.
Pirianov G; Waddington SN; Lindström TM; Terzidou V; Mehmet H; Bennett PR
Endocrinology; 2009 Feb; 150(2):699-706. PubMed ID: 18845626
[TBL] [Abstract][Full Text] [Related]
6. Regulation of proinflammatory cytokines in human gestational tissues by peroxisome proliferator-activated receptor-gamma: effect of 15-deoxy-Delta(12,14)-PGJ(2) and troglitazone.
Lappas M; Permezel M; Georgiou HM; Rice GE
J Clin Endocrinol Metab; 2002 Oct; 87(10):4667-72. PubMed ID: 12364456
[TBL] [Abstract][Full Text] [Related]
7. 15-Deoxy-Delta(12,14)-prostaglandin J(2) and troglitazone regulation of the release of phospholipid metabolites, inflammatory cytokines and proteases from human gestational tissues.
Lappas M; Permezel M; Rice GE
Placenta; 2006; 27(11-12):1060-72. PubMed ID: 16434095
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
9. 15-Deoxy-delta(12,14)-prostaglandin J(2) inhibits IL-1beta-induced IKK enzymatic activity and IkappaBalpha degradation in rat chondrocytes through a PPARgamma-independent pathway.
Boyault S; Bianchi A; Moulin D; Morin S; Francois M; Netter P; Terlain B; Bordji K
FEBS Lett; 2004 Aug; 572(1-3):33-40. PubMed ID: 15304320
[TBL] [Abstract][Full Text] [Related]
10. 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.
Straus DS; Pascual G; Li M; Welch JS; Ricote M; Hsiang CH; Sengchanthalangsy LL; Ghosh G; Glass CK
Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4844-9. PubMed ID: 10781090
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
Farrajota K; Cheng S; Martel-Pelletier J; Afif H; Pelletier JP; Li X; Ranger P; Fahmi H
Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
[TBL] [Abstract][Full Text] [Related]
12. Involvement of c-jun N-terminal kinase activation in 15-deoxy-delta12,14-prostaglandin J2-and prostaglandin A1-induced apoptosis in AGS gastric epithelial cells.
Liu JD; Lin SY; Ho YS; Pan S; Hung LF; Tsai SH; Lin JK; Liang YC
Mol Carcinog; 2003 May; 37(1):16-24. PubMed ID: 12720296
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of cyclooxygenase-2 expression by 15-deoxy-Delta(12,14)(12,14)-prostaglandin J(2) in activated human astrocytes, but not in human brain macrophages.
Janabi N
J Immunol; 2002 May; 168(9):4747-55. PubMed ID: 11971025
[TBL] [Abstract][Full Text] [Related]
14. The 15-deoxy-δ12,14-prostaglandin J2 inhibits LPS‑stimulated inflammation via enhancement of the platelet‑activating factor acetylhydrolase activity in human retinal pigment epithelial cells.
Jung WK; Lee CM; Lee DS; Na G; Lee DY; Choi I; Park SG; Seo SK; Yang JW; Choi JS; Lee YM; Park WS; Choi IW
Int J Mol Med; 2014 Feb; 33(2):449-56. PubMed ID: 24337644
[TBL] [Abstract][Full Text] [Related]
15. 15-Deoxy-Delta(12,14)-prostaglandin J(2) induces mitochondrial-dependent apoptosis through inhibition of PKA/NF-kappaB in renal proximal epithelial cells.
Lee DR; Kwon CH; Park JY; Kim YK; Woo JS
Toxicology; 2009 Apr; 258(1):17-24. PubMed ID: 19167456
[TBL] [Abstract][Full Text] [Related]
16. Protein thiol modification by 15-deoxy-Delta12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes.
Sánchez-Gómez FJ; Cernuda-Morollón E; Stamatakis K; Pérez-Sala D
Mol Pharmacol; 2004 Nov; 66(5):1349-58. PubMed ID: 15317873
[TBL] [Abstract][Full Text] [Related]
17. 15-Deoxy-Δ(12,14)-prostaglandin J2 inhibits IL-13 production in T cells via an NF-κB-dependent mechanism.
Doyle MC; Tremblay S; Dumais N
Biochem Biophys Res Commun; 2013 Feb; 431(3):472-7. PubMed ID: 23333326
[TBL] [Abstract][Full Text] [Related]
18. 15-Deoxy-delta 12,14-prostaglandin J2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF-kappa B activity and down-regulation of antiapoptotic proteins.
Piva R; Gianferretti P; Ciucci A; Taulli R; Belardo G; Santoro MG
Blood; 2005 Feb; 105(4):1750-8. PubMed ID: 15498850
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of trail gene expression by cyclopentenonic prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in T lymphocytes.
Fionda C; Nappi F; Piccoli M; Frati L; Santoni A; Cippitelli M
Mol Pharmacol; 2007 Nov; 72(5):1246-57. PubMed ID: 17673570
[TBL] [Abstract][Full Text] [Related]
20. 15-Deoxy-Delta 12,14-prostaglandin J2 inhibition of NF-kappaB-DNA binding through covalent modification of the p50 subunit.
Cernuda-Morollón E; Pineda-Molina E; Cañada FJ; Pérez-Sala D
J Biol Chem; 2001 Sep; 276(38):35530-6. PubMed ID: 11466314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
